{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:12:03Z","timestamp":1789020723934,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["cstc2021jcyj-cxtt0005"],"award-info":[{"award-number":["cstc2021jcyj-cxtt0005"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A2058"],"award-info":[{"award-number":["U20A2058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32102613"],"award-info":[{"award-number":["32102613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31830094"],"award-info":[{"award-number":["31830094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011798","name":"Ministry of Agriculture and Rural Affairs of the People's Republic of China","doi-asserted-by":"publisher","award":["CARS-18-ZJ0102"],"award-info":[{"award-number":["CARS-18-ZJ0102"]}],"id":[{"id":"10.13039\/501100011798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011798","name":"Ministry of Agriculture and Rural Affairs of the People's Republic of China","doi-asserted-by":"publisher","award":["CARS-18-ZJ0103"],"award-info":[{"award-number":["CARS-18-ZJ0103"]}],"id":[{"id":"10.13039\/501100011798","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005045","name":"Ministry of Finance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijpx.2024.100312","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T10:13:28Z","timestamp":1734257608000},"page":"100312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Hyaluronic acid\/silk fibroin nanoparticles loaded with methotrexate for topical treatment of psoriasis"],"prefix":"10.1016","volume":"9","author":[{"given":"Lan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2024.100312_bb0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijpx.2024.100312_bb0010","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijpx.2024.100312_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12325-015-0276-3","article-title":"Utilization of subcutaneous methotrexate in rheumatoid arthritis patients after failure or intolerance to oral methotrexate: a multicenter cohort study","volume":"33","author":"Branco","year":"2016","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ijpx.2024.100312_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.23144","article-title":"Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial","volume":"58","author":"Braun","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijpx.2024.100312_bb0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/ar419","article-title":"Molecular action of methotrexate in inflammatory diseases","volume":"4","author":"Chan","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.ijpx.2024.100312_bb0030","first-page":"2592","article-title":"Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells","volume":"61","author":"Eliaz","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpx.2024.100312_bb0035","first-page":"6","article-title":"Update on the pathophysiology of psoriasis","volume":"102","author":"Hugh","year":"2018","journal-title":"Cutis"},{"key":"10.1016\/j.ijpx.2024.100312_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00431-018-3286-8","article-title":"The effect of repeated methotrexate injections on the quality of life of children with rheumatic diseases","volume":"178","author":"Jacobse","year":"2019","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ijpx.2024.100312_bb0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009 national psoriasis foundation consensus conference","volume":"60","author":"Kalb","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1517\/17425247.2012.642362","article-title":"Methotrexate: a detailed review on drug delivery and clinical aspects","volume":"9","author":"Khan","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2024.100312_bb0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2012.11.006","article-title":"Hyaluronic acid-dependent protection in H9C2 cardiomyocytes: a cell model of heart ischemia-reperfusion injury and treatment","volume":"303","author":"Law","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.ijpx.2024.100312_bb0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2340\/00015555-1286","article-title":"Dermal distribution of hyaluronan in psoriatic arthritis; coexistence of CD44, MMP3 and MMP9","volume":"92","author":"Lindqvist","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0065","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.biomaterials.2010.03.033","article-title":"Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors","volume":"31","author":"Losi","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpx.2024.100312_bb0070","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/pgmj.2007.061473","article-title":"Psoriasis: advances in pathophysiology and management","volume":"83","author":"MacDonald","year":"2007","journal-title":"Postgrad. Med. J."},{"issue":"Suppl. 7","key":"10.1016\/j.ijpx.2024.100312_bb0075","first-page":"S1","article-title":"Pathophysiology of psoriasis","volume":"79","author":"Mahajan","year":"2013","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1529-8019.2010.01304.x","article-title":"Epidemiology of comorbidities in psoriasis","volume":"23","author":"Naldi","year":"2010","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.ijpx.2024.100312_bb0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/1061186X.2012.702767","article-title":"Role of CD44 in tumour progression and strategies for targeting","volume":"20","author":"Negi","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpx.2024.100312_bb0090","first-page":"13","article-title":"Transdermal delivery of chemotherapeutics: strategies, requirements, and opportunities","author":"Neupane","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2024.100312_bb0095","first-page":"11","article-title":"Silk fibroin-based biomaterials for biomedical applications: a review","author":"Nguyen","year":"2019","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijpx.2024.100312_bb0100","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0105","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nbt.1504","article-title":"Transdermal drug delivery","volume":"26","author":"Prausnitz","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0110","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4155\/tde.12.5","article-title":"Advancing transdermal drug-delivery systems past development barriers to the clinic: an industry perspective","volume":"3","author":"Quan","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijpx.2024.100312_bb0115","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17425247.2020.1758665","article-title":"Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis","volume":"17","author":"Saleem","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpx.2024.100312_bb0120","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1468-3083.2010.03574.x","article-title":"Psoriatic disease: concepts and implications","volume":"24","author":"Scarpa","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0125","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/adhm.201300034","article-title":"pH-dependent anticancer drug release from silk nanoparticles","volume":"2","author":"Seib","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijpx.2024.100312_bb0130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2018.03.018","article-title":"Anti-IL-12\/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis","volume":"828","author":"Takahashi","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","article-title":"Psoriasis and comorbid diseases: implications for management","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijpx.2024.100312_bb0145","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.colsurfb.2018.12.012","article-title":"Transdermal delivery of 40-nm silk fibroin nanoparticles","volume":"175","author":"Takeuchi","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpx.2024.100312_bb0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2014.05.022","article-title":"Transdermal drug delivery: 30+ years of war and still fighting!","volume":"190","author":"Wiedersberg","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2024.100312_bb0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno.29715","article-title":"CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified ethosomes: a new strategy for clustering drug in inflammatory skin","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ijpx.2024.100312_bb0160","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.3390\/ijms16034880","article-title":"Silk fibroin-based nanoparticles for drug delivery","volume":"16","author":"Zhao","year":"2015","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156724000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156724000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T20:46:57Z","timestamp":1762634817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156724000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"alternative-id":["S2590156724000847"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2024.100312","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid\/silk fibroin nanoparticles loaded with methotrexate for topical treatment of psoriasis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2024.100312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100312"}}